Miller PD, Yu Z. Reply to Letter to the Editor: Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease. J Bone Miner Res 2023 Jan 25. doi: 10.1002/jbmr.4761.
PMID: 36698050